Article Information
PubMed
Published By
History
- Received June 8, 2004
- Revision received November 18, 2004
- Accepted November 18, 2004
- First published January 12, 2005.
- Version of record published January 12, 2005.
Copyright & Usage
Copyright © 2005 Society for Neuroscience 0270-6474/05/25372-12.00/0
Author Information
- Takanori Hashimoto1,
- Sarah E. Bergen2,
- Quyen L. Nguyen2,
- Baoji Xu4,
- Lisa M. Monteggia5,
- Joseph N. Pierri1,
- Zhuoxin Sun3,
- Allan R. Sampson3, and
- David A. Lewis1,2
- Departments of 1Psychiatry, 2Neuroscience, and 3Statistics, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, 4Department of Pharmacology, Georgetown University Medical School, Washington, DC 20057, and 5Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390
Author contributions
Disclosures
- Received June 8, 2004.
- Revision received November 18, 2004.
- Accepted November 18, 2004.
This work was supported by National Institutes of Health Grants MH43784 (D.A.L.), MH45156 (D.A.L.), and NS16033, by an investigator-initiated grant from Pfizer (D.A.L.), and by a National Alliance for Research on Schizophrenia and Depression Young Investigator Award (T.H.). We thank Sarah Ng, Aniko Evans, Leah M. Konopka, Erastus Allen, and Mary L. Brady for technical assistance.
Correspondence should be addressed to Dr. David A. Lewis, Department of Psychiatry, University of Pittsburgh, W1650 Biomedical Science Tower, 3811 O'Hara Street, Pittsburgh, PA 15213. E-mail: lewisda{at}upmc.edu.
Copyright © 2005 Society for Neuroscience 0270-6474/05/250372-12$15.00/0
Online Impact